1. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. (March 2020) Authors: Fisher, Benjamin A; Szanto, Antonia; Ng, Wan-Fai; Bombardieri, Michele; Posch, Maximilian G; Papas, Athena S; Farag, Arwa M; Daikeler, Thomas; Bannert, Bettina; Kyburz, Diego; Kivitz, Alan J; Carsons, Steven E; Isenberg, David A; Barone, Francesca; Bowman, Simon J; Espié, Pascal; Floch, David; Du... Journal: Lancet Issue: Volume 2:Number 3(2020) Page Start: e142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. (4th May 2021) Authors: Rojas, Julio C.; Wang, Ping; Staffaroni, Adam M.; Heller, Carolin; Cobigo, Yann; Wolf, Amy; Goh, Sheng-Yang M.; Ljubenkov, Peter A.; Heuer, Hilary W.; Fong, Jamie C.; Taylor, Joanne B.; Veras, Eliseo; Song, Linan; Jeromin, Andreas; Hanlon, David; Yu, Lili; Khinikar, Arvind; Sivasankaran, Rajeev; ... Journal: Neurology Issue: Volume 96:Number 18(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Issue 9 (September 2021) Authors: Thijssen, Elisabeth H; La Joie, Renaud; Strom, Amelia; Fonseca, Corrina; Iaccarino, Leonardo; Wolf, Amy; Spina, Salvatore; Allen, Isabel E; Cobigo, Yann; Heuer, Hilary; VandeVrede, Lawren; Proctor, Nicholas K; Lago, Argentina Lario; Baker, Suzanne; Sivasankaran, Rajeev; Kieloch, Agnieszka; Kinhik... Journal: Lancet neurology Issue: Volume 20:Issue 9(2021) Page Start: 739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Therapeutic equivalence of vildagliptin 100 mg once daily modified release to 50 mg twice daily immediate release formulation: An open-label, randomized, two-period, single- and multiple-dose, 6-day crossover study. Issue 3 (March 2022) Authors: Sangana, Ramachandra; Mittal, Hemant; Barsainya, Sarita; Hoermann, Aldo; Borde, Parag; Naik, Sachin; Thorat, Anup Vilas; Zhang, Jie; Valentin, Marie-Anne; Kalluri, Sampath Journal: Diabetes & metabolic syndrome Issue: Volume 16:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy. Issue 1 (December 2017) Authors: Brachat, Arndt; Grom, Alexei; Wulffraat, Nico; Brunner, Hermine; Quartier, Pierre; Brik, Riva; McCann, Liza; Ozdogan, Huri; Rutkowska-Sak, Lidia; Schneider, Rayfel; Gerloni, Valeria; Harel, Liora; Terreri, Maria; Houghton, Kristin; Joos, Rik; Kingsbury, Daniel; Lopez-Benitez, Jorge; Bek, Stephan;... Journal: Arthritis research & therapy Issue: Volume 19:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity. Issue 5 (11th May 2019) Authors: Dörner, Thomas; Posch, Maximilian Georg; Li, Yue; Petricoul, Olivier; Cabanski, Maciej; Milojevic, Julie Marie; Kamphausen, Esther; Valentin, Marie-Anne; Simonett, Claudia; Mooney, Louise; Hüser, Andreas; Gram, Hermann; Wagner, Frank Dietrich; Oliver, Stephen John Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 5(2019) Page Start: 641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel microperfusion method confirms higher IL-17A and β-defensin-2 levels in psoriasis lesional skin compared to non-lesional skin. Issue 1 (October 2016) Authors: Loesche, Christian; Bruin, Gerardus; Valentin, Marie-Anne; Polus, Florine; Kolbinger, Frank; Sinner, Frank Journal: Journal of dermatological science Issue: Volume 84:Issue 1(2016:Oct.) Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Secukinumab treatment rapidly leads to positive proteomic and transcriptional changes in psoriatic skin. Issue 1 (October 2016) Authors: Kolbinger, Frank; Bruin, Gerardus; Valentin, Marie-Anne; Peters, Thomas; Khokhlovich, Edward; Jiang, Xiuyun; Koroleva, Irina; Lee, David; Sinner, Frank; Pieber, Thomas; Dragatin, Christian; Bodenlenz, Manfred; Loesche, Christian Journal: Journal of dermatological science Issue: Volume 84:Issue 1(2016:Oct.) Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity. Issue 5 (2nd March 2019) Authors: Dörner, Thomas; Posch, Maximilian Georg; Li, Yue; Petricoul, Olivier; Cabanski, Maciej; Milojevic, Julie Marie; Kamphausen, Esther; Valentin, Marie-Anne; Simonett, Claudia; Mooney, Louise; Hüser, Andreas; Gram, Hermann; Wagner, Frank Dietrich; Oliver, Stephen John Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 5(2019) Page Start: 641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗